Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationHKSE:01763 +0.95%92 Gross Margin % is 49.93% as of Dec. 2025, which is 20% below its 10-year median of 62.12. GuruFocus rates HKSE:01763 with a GF Score™ of 92/100 and a GF Value™ of HK$15.74 (Fairly Valued). The stock has 5 warning signs investors should review. Among 804 Medical Devices & Instruments companies, China Isotope & Radiation ranks worse than 52.24% on this metric.
HKSE:01763's Gross Margin % is ranked worse than 52.24% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.34
vs HKSE:01763: 50.38
China Isotope & Radiation had a gross margin of 49.93% for the quarter that ended in Dec. 2025 => Durable competitive advantage
China Isotope & Radiation (HKSE:01763) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
China Isotope & Radiation had a gross margin of 49.93% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
China Isotope & Radiation Gross Margin % Related Terms
China Isotope & Radiation Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01763 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, China Isotope & Radiation's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Gross Margin % distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
China Isotope & Radiation (HKSE:01763) has a Gross Margin % of 49.93% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on China Isotope & Radiation and its competitors. This is 20% below median its historical median of 62.12. Over the past decade, China Isotope & Radiation's Gross Margin % has ranged from 48.62 to 70.93. According to the industry distribution chart, China Isotope & Radiation ranks #420 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 52.2%.
Is China Isotope & Radiation's Gross Margin % too high?
China Isotope & Radiation's current Gross Margin % of 49.93% is 20% below median its 10-year median of 62.12. Over the past 10 years, this metric has ranged from a low of 48.62 to a high of 70.93. The Medical Devices & Instruments industry median Gross Margin % is 52.34. China Isotope & Radiation's value of 49.93% is 4.6% below this industry median. Based on the distribution chart, China Isotope & Radiation ranks #420 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, China Isotope & Radiation has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #420 out of 804 companies for Gross Margin %. This places China Isotope & Radiation in the lower half of its industry. The industry median Gross Margin % is 52.34. China Isotope & Radiation's value of 49.93% is 4.6% below this benchmark. Historically, China Isotope & Radiation's own Gross Margin % has ranged from 48.62 to 70.93 over the past decade. While the company's 10-year median is 62.12 vs. the industry median of 52.34, China Isotope & Radiation has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.34, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current Gross Margin % of 49.93% is 4.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current Gross Margin % is 49.93%, which is 20% below median its own 10-year median of 62.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Fairly Valued. The stock's GF Value™ is HK$15.74, compared to a current price of HK$17.02 — trading 8.1% above its estimated fair value. The current Gross Margin % is 49.93%, which is 20% below median its 10-year median of 62.12 and 4.6% below the Medical Devices & Instruments industry median of 52.34. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current Gross Margin % is 49.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of HK$17.02 is trading 8.1% above its estimated GF Value™ of HK$15.74.
GuruFocus considers China Isotope & Radiation to be Fairly Valued.
Key valuation signals for HKSE:01763:
Gross Margin %: 49.93% (20% below median its 10-year median of 62.12)
GF Value™: HK$15.74 vs. price of HK$17.02 (8.1% above fair value)
Industry Position: 4.6% below the Medical Devices & Instruments median (#420 of 804)
No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for HKSE:01763
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01763 has been successfully added to your 
